Every SEC Form 3/4/5 on record for this filer (CIK 1801385) — 1 issuer, 96 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| KRYS | Krystal Biotech, Inc. | Chief Accounting Officer | 2020-02-25 → 2026-03-03 | 13 | −$13M |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| KRYS | 2026-03-02 | Sell | 750 | $267.60 | $200,700 | 22,366 |
| KRYS | 2026-02-09 | Sell | 2,000 | $270.56 | $541,120 | 29,818 |
| KRYS | 2026-02-09 | Sell | 5,700 | $271.66 | $2M | 24,118 |
| KRYS | 2026-02-09 | Sell | 928 | $273.71 | $254,003 | 20,366 |
| KRYS | 2026-02-09 | Sell | 552 | $274.64 | $151,601 | 19,814 |
1 of 1 issuers are covered and open a security page; the rest are on file here only.